Page 3 - Theodore Gerbick News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Navidea Biopharmaceuticals, Inc Reports First Quarter 2023 Financial Results and Provides Business Update

Navidea Biopharmaceuticals, Inc Reports First Quarter 2023 Financial Results and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAlexanderl cappelloSimon alder blackburnJill bieker stefanelliMichael rosolJason myersTheodore gerbickNavidea manoceptJoshua wilsonJohnk scott jrConsulting services agreementSecurities exchangeCompany board of directorsClinical researchDevelopment expensesKeystone capital partners

Navidea Biopharmaceuticals, Inc Welcomes Jill Bieker Stefanelli, Ph D to Board of Directors; Alexa

In line with the Company’s Fix, Fund, Propel approach, Jill Bieker Stefanelli, Ph.D. joins Board, adding precision medicine and product development depth in support of stated strategy to advance innovative technology to market. Separately, Alexander L. Cappello steps down.DUBLIN, Ohio (BUSINESS WIRE) Navidea Bioph.

United statesJason myersJill bieker stefanelliAlexanderl cappelloTheodore gerbickNavidea manoceptInvitae archerJohnk scott jrSandia national laboratoriesAnimal sciences industrySecurities exchangeNavidea biopharmaceuticals incPrecision medicine companiesCompany fixCompany board of directorsCompany board

Navidea Biopharmaceuticals, Inc Receives NYSE American Notice

Navidea Biopharmaceuticals, Inc Receives NYSE American Notice
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesTheodore gerbickNavidea manoceptExchange commissionAmerican company guideSecurities exchangeNavidea biopharmaceuticals incWall streetCompany guideSecurities actSecurities exchange actAnnual reportNavidea biopharmaceuticals

Stock Market | FinancialContent Business Page

FinancialContent fully hosted finance channel

United statesNavidea manoceptTheodore gerbickNavidea biopharmaceuticals incSecurities exchangeAmerican company guideExchange commissionNavidea biopharmaceuticalsCompany guideSecurities actSecurities exchange actAnnual report

Navidea Biopharmaceuticals, Inc Investors Purchase $1 1 Million in Preferred Shares at Market

Navidea Biopharmaceuticals, Inc Investors Purchase $1 1 Million in Preferred Shares at Market
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNavidea manoceptTheodore gerbickExchange commissionNavidea biopharmaceuticals incCompany fixSecurities exchangeWall streetPreferred sharesAdds confidenceMichael blueChief medical officerSecurities actSecurities exchange actAnnual reportNavidea biopharmaceuticals